ARL4C and colorectal carcinoma: Molecular docking analysis identified multiple binding sites between ARL4C and RAP1A (Figure 6D, Figure S8B, Table S5), and immunofluorescence staining demonstrated their co-localization in CRC cells (Figure 6E).